Exclusive

Publication

Byline

US Patent Issued to Intel on April 7 for "Mid-valent molybdenum complexes for thin film deposition" (Oregon Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,276, issued on April 7, was assigned to Intel Corp. (Santa Clara, Calif.). "Mid-valent molybdenum complexes for thin film deposition" was i... Read More


US Patent Issued to BEIJING SUMMER SPROUT TECHNOLOGY on April 7 for "Light-emitting material with a polycyclic ligand" (Chinese Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,277, issued on April 7, was assigned to BEIJING SUMMER SPROUT TECHNOLOGY Co. LTD. (Beijing). "Light-emitting material with a polycyclic lig... Read More


US Patent Issued to REATA PHARMACEUTICALS on April 7 for "Biaryl amides with modified sugar groups for treatment of diseases associated with heat shock protein pathway" (Texas, Michigan Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,278, issued on April 7, was assigned to REATA PHARMACEUTICALS INC (Irving, Texas). "Biaryl amides with modified sugar groups for treatment ... Read More


US Patent Issued to STEMIRNA THERAPEUTICS on April 7 for "Modified nucleoside and synthetic methods thereof" (Chinese Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,279, issued on April 7, was assigned to STEMIRNA THERAPEUTICS Co. LTD. (Shanghai). "Modified nucleoside and synthetic methods thereof" was ... Read More


US Patent Issued to EMORY UNIVERSITY on April 7 for "Phosphoramidates for the treatment of hepatitis B virus" (Georgia Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,280, issued on April 7, was assigned to EMORY UNIVERSITY (Atlanta). "Phosphoramidates for the treatment of hepatitis B virus" was invented ... Read More


US Patent Issued to The Government of the United States of America, as represented by the Secretary of the Navy on April 7 for "Indodicarbocyanine phosphoramidites with bathochromically shifted absorption and emission, and tunable hydrophobicity" (District Of Columbia, Idaho, Virginia Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,281, issued on April 7, was assigned to The Government of the United States of America, as represented by the Secretary of the Navy (Arlingt... Read More


US Patent Issued to HONGENE BIOTECH on April 7 for "Method for synthesizing nucleotide strands" (Singaporean Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,282, issued on April 7, was assigned to HONGENE BIOTECH PTE. LTD. (Singapore). "Method for synthesizing nucleotide strands" was invented by... Read More


US Patent Issued to KANGMA-HEALTHCODE (SHANGHAI) BIOTECH on April 7 for "Polypeptide tag and application thereof in in vitro protein synthesis" (Chinese Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,283, issued on April 7, was assigned to KANGMA-HEALTHCODE (SHANGHAI) BIOTECH Co. LTD (Shanghai). "Polypeptide tag and application thereof i... Read More


US Patent Issued to Heidelberg Pharma Research on April 7 for "Amatoxin antibody-drug conjugates and uses thereof" (American, German Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,284, issued on April 7, was assigned to Heidelberg Pharma Research GmbH (Ladenburg, Germany). "Amatoxin antibody-drug conjugates and uses t... Read More


US Patent Issued to Dana-Farber Cancer Institute on April 7 for "LMP-1 expressing cells and methods of use thereof" (Massachusetts Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,285, issued on April 7, was assigned to Dana-Farber Cancer Institute Inc. (Boston). "LMP-1 expressing cells and methods of use thereof" was... Read More